Enosumab Solution for Injection

Esentra 120 (Denosumab) is a specialized biological therapy formulated as a solution for subcutaneous injection, manufactured under stringent quality standards by Intas Pharmaceuticals. Containing $120\text{ mg}$ of the active ingredient per $1.7\text{ mL}$ vial, this targeted monoclonal antibody functions as a RANK ligand inhibitor. It is primarily prescribed in clinical oncology and bone care settings to prevent skeletal-related events, such as bone fractures and radiation therapies, in patients dealing with advanced malignancies or giant cell tumors of the bone. Designed strictly for subcutaneous administration, it must be stored under refrigeration ($2^\circ\text{C}$ to $8^\circ\text{C}$) to maintain its stability and therapeutic efficacy.